Bonk, Inc. (NASDAQ:BNKK) Sees Large Drop in Short Interest

Bonk, Inc. (NASDAQ:BNKK) saw a significant decrease in short interest during the month of May. As of May 29th, there was short interest totaling 426,285 shares, a decrease of 48.9% from the May 14th total of 834,243 shares. Approximately 11.0% of the shares of the stock are short sold. Based on an average daily volume of 547,519 shares, the short-interest ratio is presently 0.8 days.

Bonk Stock Performance

BNKK traded down $0.06 during midday trading on Friday, hitting $1.35. The stock had a trading volume of 543,570 shares, compared to its average volume of 441,784. The company has a market cap of $10.80 million, a P/E ratio of -0.29 and a beta of 1.85. The business has a fifty day moving average of $2.26 and a 200 day moving average of $3.26. Bonk has a 1 year low of $1.25 and a 1 year high of $46.90.

Bonk (NASDAQ:BNKK) last issued its earnings results on Wednesday, May 13th. The company reported ($0.23) earnings per share (EPS) for the quarter. The firm had revenue of $0.79 million during the quarter. Bonk had a negative return on equity of 148.62% and a negative net margin of 838.37%.

Analyst Upgrades and Downgrades

BNKK has been the topic of several research analyst reports. Weiss Ratings cut shares of Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, April 29th. Wall Street Zen upgraded shares of Bonk from a “sell” rating to a “hold” rating in a research report on Saturday. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has an average rating of “Sell”.

Insider Buying and Selling at Bonk

In related news, Director Mitchell Austin Rudy acquired 31,055 shares of the firm’s stock in a transaction that occurred on Thursday, April 9th. The shares were bought at an average cost of $2.82 per share, for a total transaction of $87,575.10. Following the completion of the transaction, the director owned 44,198 shares in the company, valued at approximately $124,638.36. This trade represents a 236.29% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 51.60% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in BNKK. State Street Corp bought a new position in shares of Bonk in the fourth quarter worth approximately $33,000. Steward Partners Investment Advisory LLC bought a new position in shares of Bonk in the fourth quarter worth approximately $37,000. Jane Street Group LLC bought a new position in shares of Bonk in the fourth quarter worth approximately $96,000. Finally, Geode Capital Management LLC bought a new position in shares of Bonk in the fourth quarter worth approximately $128,000. Institutional investors own 12.55% of the company’s stock.

Bonk Company Profile

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.